Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method

Journal of Lipid Research

Volumn 53, Issue 10, 2012, Pages 2231-2241

  García Cañaveras, Juan C ^a,b   Donato, M Teresa ^a,b,c   Castell, José V ^a,b,c   Lahoz, Agustín ^a,b,c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Lipidomics; Metabolomics; Targeted analysis

Indexed keywords

BETA MURICHOLIC ACID; BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEHYDROCHOLIC ACID; DEOXYCHOLIC ACID; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCODEHYDROCHOLIC ACID; GLYCOHYDROCHOLIC ACID; GLYCOHYDRODEOXYCHOLIC ACID; HYOCHOLIC ACID; HYODEOXYCHOLIC ACID; LITHOCHOLIC ACID; OMEGA MURICHOLIC ACID; TAURO ALPHA MURICHOLIC ACID; TAURO OMEGA MURICHOLIC ACID; TAUROCHOLIC ACID; TAURODEHYDROCHOLIC ACID; TAUROHYOCHOLIC ACID; TAUROHYODEOXYCHOLIC ACID; TAUROLITHOCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; BILE ACID BLOOD LEVEL; BILE ACID LIVER LEVEL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; LIMIT OF QUANTITATION; LIPID ANALYSIS; LIPID LIVER LEVEL; MALE; MASS SPECTROMETRY; MOUSE; MULTIPLE REACTION MONITORING MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RAT; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SPECIES COMPARISON; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ANIMALS; BILE ACIDS AND SALTS; CHROMATOGRAPHY, LIQUID; HUMANS; LIVER; MALE; MASS SPECTROMETRY; MICE; RATS; SPECIES SPECIFICITY; TAUROCHOLIC ACID;

EID: 84866183656     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D028803     Document Type: Article

References (40)

1. Botham, K. M., and G. S. Boyd, 1983, The metabolism of chenodeoxycholic acid to beta-muricholic acid in rat liver. Eur. J. Biochem. 134: 191-196,
2. Eyssen, H., G. De Pauw, J. Stragier, and A. Verhulst, 1983, Cooperative formation of omega-muricholic acid by intestinal microorganisms. Appl. Environ. Microbiol. 45: 141-147,
3. Hofmann, A. F., and L. R. Hagey, 2008, Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell. Mol. Life Sci. 65: 2461-2483,
4. Chiang, J. Y. 2009, Bile acids: regulation of synthesis. J. Lipid Res. 50: 1955-1966,
5. Hylemon, P. B., H. Zhou, W. M. Pandak, S. Ren, G. Gil, and P. Dent, 2009, Bile acids as regulatory molecules. J. Lipid Res. 50: 1509-1520,
6. Khan, A. A., E. C. Chow, R. J. Porte, K. S. Pang, and G. M. Groothuis, 2011, The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices. Toxicol. In Vitro, 25: 80-90,
7. Pols, T. W., L. G. Noriega, M. Nomura, J. Auwerx, and K. Schoonjans, 2011, The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J. Hepatol. 54: 1263-1272,
8. Reschly, E. J., and M. D. Krasowski, 2006, Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr. Drug Metab. 7: 349-365,
9. Thomas, C., R. Pellicciari, M. Pruzanski, J. Auwerx, and K. Schoonjans, 2008, Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 7: 678-693,
10. Trottier, J., A. Bialek, P. Caron, R. J. Straka, P. Milkiewicz, and O. Barbier, 2011, Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting. PLoS ONE, 6: e22094,
11. Want, E. J., M. Coen, P. Masson, H. C. Keun, J. T. Pearce, M. D. Reily, D. G. Robertson, C. M. Rohde, E. Holmes, J. C. Lindon, et al, 2010, Ultra performance liquid chromatography-mass spectrometry profiling of bile acid metabolites in biofluids: application to experimental toxicology studies. Anal. Chem. 82: 5282-5289,
12. Yang, L., A. Xiong, Y. He, Z. Wang, C. Wang, W. Li, and Z. Hu, 2008, Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry. Chem. Res. Toxicol. 21: 2280-2288,
13. Trottier, J., A. Bialek, P. Caron, R. J. Straka, J. Heathcote, P. Milkiewicz, and O. Barbier, 2012, Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. Dig. Liver Dis. 44: 303-310,
14. Palmeira, C. M., and A. P. Rolo, 2004, Mitochondrially-mediated toxicity of bile acids. Toxicology, 203: 1-15,
15. Reddy, B. S., K. Watanabe, J. H. Weisburger, and E. L. Wynder, 1977, Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 37: 3238-3242,
16. Monte, M. J., M. C. Martinez-Diez, M. Y. El-Mir, M. E. Mendoza, P. Bravo, O. Bachs, and J. J. Marin, 2002, Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration. J. Hepatol. 36: 534-542,
17. Garcia-Canaveras, J. C., M. T. Donato, J. V. Castell, and A. Lahoz, 2011, A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. J. Proteome Res. 10: 4825-4834,
18. Legido-Quigley, C., L. McDermott, H. Vilca-Melendez, G. M. Murphy, N. Heaton, J. C. Lindon, J. K. Nicholson, and E. Holmes, 2011, Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation. Electrophoresis, 32: 2063-2070,
19. Griffiths, W. J., and J. Sjovall, 2010, Bile acids: analysis in biological fluids and tissues. J. Lipid Res. 51: 23-41,
20. Bobeldijk, I., M. Hekman, J. de Vries-van der Weij, L. Coulier, R. Ramaker, R. Kleemann, T. Kooistra, C. Rubingh, A. Freidig, and E. Verheij, 2008, Quantitative profiling of bile acids in biofluids and tissues based on accurate mass high resolution LC-FT-MS: compound class targeting in a metabolomics workflow. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871: 306-313,
21. Steiner, C., A. von Eckardstein, and K. M. Rentsch, 2010, Quantification of the 15 major human bile acids and their precursor 7alpha-hydroxy-4-cholesten- 3-one in serum by liquid chromatography- tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878: 2870-2880,
22. Huang, J., S. P. Bathena, I. L. Csanaky, and Y. Alnouti, 2011, Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using LC-MS/MS. J. Pharm. Biomed. Anal. 55: 1111-1119,
23. Alnouti, Y., I. L. Csanaky, and C. D. Klaassen, 2008, Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 873: 209-217,
24. Ando, M., T. Kaneko, R. Watanabe, S. Kikuchi, T. Goto, T. Iida, T. Hishinuma, N. Mano, and J. Goto, 2006, High sensitive analysis of rat serum bile acids by liquid chromatography/electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 40: 1179-1186,
25. Honda, A., K. Yamashita, M. Numazawa, T. Ikegami, M. Doy, Y. Matsuzaki, and H. Miyazaki, 2007, Highly sensitive quantification of 7alpha-hydroxy-4- cholesten-3-one in human serum by LC-ESI-MS/MS. J. Lipid Res. 48: 458-464,
26. Nakashima, T., Y. Sakamoto, K. Inaba, H. Mitsuyoshi, H. Ishikawa, Y. Nakajima, M. Sakai, T. Shima, and K. Kashima, 1999, A paucity of unusual trihydroxy bile acids in the urine of patients with severe liver diseases. Hepatology, 29: 1518-1522,
27. FDA, 2001, Guidance for industry: bioanalytical method validation. FDA, Washington, DC.
28. Ye, L., S. Liu, M. Wang, Y. Shao, and M. Ding, 2007, High-performance liquid chromatography-tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 860: 10-17,
29. McRae, M., N. L. Rezk, A. S. Bridges, A. H. Corbett, H. C. Tien, K. L. Brouwer, and A. D. Kashuba, 2010, Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity. Pharmacotherapy, 30: 17-24,
30. Burkard, I., A. von Eckardstein, and K. M. Rentsch, 2005, Differentiated quantification of human bile acids in serum by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 826: 147-159,
31. Aoki, M., Y. Konya, T. Takagaki, K. Umemura, Y. Sogame, T. Katsumata, and S. Komuro, 2011, Metabolomic investigation of cholestasis in a rat model using ultra-performance liquid chromatography/ tandem mass spectrometry. Rapid Commun. Mass Spectrom. 25: 1847-1852,
32. Xiang, X., Y. Han, M. Neuvonen, J. Laitila, P. J. Neuvonen, and M. Niemi, 2010, High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878: 51-60,
33. Tessier, E., L. Neirinck, and Z. Zhu, 2003, High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 798: 295-302,
34. Hagio, M., M. Matsumoto, M. Fukushima, H. Hara, and S. Ishizuka, 2009, Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS. J. Lipid Res. 50: 173-180,
35. Scherer, M., C. Gnewuch, G. Schmitz, and G. Liebisch, 2009, Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 3920-3925,
36. Tagliacozzi, D., A. F. Mozzi, B. Casetta, P. Bertucci, S. Bernardini, C. Di Ilio, A. Urbani, and G. Federici, 2003, Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin. Chem. Lab. Med. 41: 1633-1641,
37. Mendoza, M. E., M. J. Monte, M. Y. El-Mir, M. D. Badia, and J. J. Marin, 2002, Changes in the pattern of bile acids in the nuclei of rat liver cells during hepatocarcinogenesis. Clin. Sci. (Lond.), 102: 143-150,
38. Batta, A. K., R. Arora, G. Salen, G. S. Tint, D. Eskreis, and S. Katz, 1989, Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment. J. Lipid Res. 30: 1953-1962,
39. Nakashima, T., A. Sano, Y. Seto, T. Nakajima, T. Shima, Y. Sakamoto, T. Okuno, K. Kashima, and T. Hasegawa, 1990, Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis. Hepatology, 11: 255-260,
40. Hofmann, A. F., L. R. Hagey, and M. D. Krasowski, 2010, Bile salts of vertebrates: structural variation and possible evolutionary significance. J. Lipid Res. 51: 226-246,